|
Completed
|
NCT05020249 -
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
|
Phase 3 |
|
Completed
|
NCT01202565 -
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
|
N/A |
|
Recruiting
|
NCT05258331 -
Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis
|
Phase 1 |
|
Withdrawn
|
NCT03146247 -
Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
|
Phase 4 |
|
Recruiting
|
NCT04367441 -
Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects
|
Phase 1 |
|
Completed
|
NCT01644396 -
An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian Federation
|
Phase 4 |
|
Completed
|
NCT01622348 -
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
|
Phase 2 |
|
Recruiting
|
NCT04566666 -
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
|
Phase 2 |
|
Active, not recruiting
|
NCT05155098 -
2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis
|
|
|
Completed
|
NCT01555606 -
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
|
Phase 4 |
|
Completed
|
NCT02713295 -
A Study to Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece
|
|
|
Completed
|
NCT05342428 -
Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis
|
Phase 1 |
|
Completed
|
NCT04967508 -
A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque Psoriasis
|
Phase 3 |
|
Completed
|
NCT00710580 -
Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
|
Phase 3 |
|
Recruiting
|
NCT06109818 -
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
|
Phase 2 |
|
Completed
|
NCT01077232 -
Documentation of Humira in Psoriasis Patients in Routine Clinical Practice
|
|
|
Completed
|
NCT03412747 -
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
|
Phase 3 |
|
Completed
|
NCT02982005 -
A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
|
Phase 3 |
|
Completed
|
NCT00626002 -
Open Label Continuation Study in Moderate to Severe Psoriasis
|
Phase 3 |
|
Completed
|
NCT02660580 -
MSB11022 in Moderate to Severe Chronic Plaque Psoriasis
|
Phase 3 |